
7 Strategies for B2B Healthcare Technology Companies to Build Real Authority (2026)
For B2B healthcare technology, 2026 is an existential moment. Here are 7 strategies that separate noisy vendors from trusted partners.
In a recent, illuminating podcast interview, Lex Fridman sat down with key figures from Neuralink, including CEO Elon Musk, to discuss the company’s revolutionary brain-computer interface (BCI) technology. The conversation, which included insights from Neuralink’s first human participant, Noland Arbaugh, shed light on the incredible progress and potential of this cutting-edge innovation.
Neuralink’s human trials have shattered previous records in BCI performance. Noland Arbaugh, paralyzed from the shoulders down, demonstrated exceptional control over a computer cursor using only his thoughts. Elon Musk revealed a stunning achievement: “We were able to get to achieve a bit per second. That’s twice the world record.” This feat is even more impressive considering it was accomplished with only 10-15% of the implant’s electrodes functioning optimally.
Arbaugh’s progress has been remarkable. He achieved a peak performance of 8.5 bits per second (BPS) in the Webgrid task, a standardized measure of BCI effectiveness. This score represents a 185% improvement over the previous human BCI record of 4.5 BPS. To put this in perspective, the median able-bodied person using a computer mouse achieves around 10 BPS in the same task.
Building on this success, Neuralink’s second participant, Alex, has shown equally promising results. Within just one week of receiving the implant, Alex was able to play online chess using only his thoughts to move the cursor. This rapid progress demonstrates the consistency and potential of Neuralink’s technology across different individuals.
The pace of Neuralink’s progress is astounding. Musk projects that within five years, their technology could potentially achieve data transfer rates of one megabit per second – a thousandfold increase from current capabilities and faster than any human could communicate by typing or speaking.
DJ Seo, COO & President of Neuralink, explained the company’s unique thread-based electrode system: “The current instantiation of the device has 64 threads, and each thread has 16 electrodes for a total of 1,024 electrodes that are capable of both recording and stimulating.” This design allows for an electrode density approximately 100 times higher than traditional BCIs, potentially leading to more precise control and expanded capabilities.
The N1 implant is a marvel of miniaturization. With dimensions of just 23mm x 8mm and a thickness of 4mm, it’s about the size of five stacked quarters. Despite its small size, it houses a custom chip capable of processing 48Mb/s of neural data across all channels. This real-time processing power is crucial for the seamless control demonstrated by both Noland and Alex.
While the current focus is on restoring communication and control for individuals with paralysis, Neuralink’s technology holds promise for a wide range of neurological conditions. Dr. Matthew MacDougall, Head Neurosurgeon at Neuralink, highlighted this potential: “There are legitimate targets in the brain for doing that. Things that aren’t immediately obvious as brain problems are potentially solvable in the brain.”
One particularly exciting area of development is Neuralink’s work on vision restoration. The company has mentioned plans for a product called Blindsight, which aims to restore vision by directly stimulating the visual cortex. This could potentially help the estimated 39 million people worldwide who are blind, according to World Health Organization statistics.
Neuralink has implemented rigorous safety protocols, working closely with regulatory bodies to ensure the highest standards are met. The successful implantation and initial results from two participants without major complications further validates Neuralink’s commitment to safety and ethical practices.
Dr. MacDougall emphasized the company’s safety goals: “We start from the position that we want this to be dramatically maybe two or three orders of magnitude safer than that, safe enough, really, that you or I, without a profound medical problem, might on our lunch break someday say, ‘Yeah, sure, I’ll get that.'”
Neuralink’s approach to development is highly user-centric, with constant feedback and iteration based on user experience. This focus has led to rapid improvements in the technology. Noland Arbaugh’s experience exemplifies this progress: within just a few months, he went from basic cursor control to playing complex video games and even setting new BCI performance records.
The company’s custom software interface allows for remarkable adaptability. Users can adjust parameters such as cursor sensitivity and click timing, enabling fine-tuning of the experience to individual preferences. This level of customization has contributed to the rapid progress observed in both Noland and Alex.
While the immediate focus is on medical applications, the long-term vision for Neuralink’s technology is expansive. Musk envisions a future where BCIs could enhance human cognition and enable direct brain-to-brain communication. He stated, “The long-term aspiration of Neuralink is to improve the AI human symbiosis by increasing the bandwidth of the communication.”
The implications of high-bandwidth brain-computer interfaces are staggering. In education, for instance, direct neural interfaces could potentially accelerate learning rates by orders of magnitude. In the realm of creativity, BCIs could enable artists and designers to translate their imaginations directly into digital creations with unprecedented fidelity.
Moreover, the potential for BCIs to facilitate direct brain-to-brain communication opens up entirely new paradigms for human collaboration and understanding. While still speculative, the ability to share thoughts, emotions, and experiences directly could fundamentally transform how we relate to one another and understand different perspectives.
In conclusion, Neuralink’s work represents a paradigm shift in how we interact with technology and potentially how we understand and treat neurological conditions. The success with multiple participants demonstrates the reproducibility and potential scalability of their technology. As the company continues to push the boundaries of what’s possible, the implications for healthcare, communication, and human augmentation are profound.
The progress made thus far suggests a future where the limitations of the human body may be overcome through the power of direct brain-computer interfaces. With each milestone achieved, Neuralink is not just advancing technology – they’re redefining the very nature of human potential.
Dr. Steve Ambrose is a 30+ year healthcare and health technology veteran, who has developed thought leadership content and strategy for organizations valued at more than $3Billion, as well as C-suite leaders, SMEs, and well-known brands.
If you’re an organization or an executive seeking to add and improve the quality and impact of your thought leadership, please review the following:

For B2B healthcare technology, 2026 is an existential moment. Here are 7 strategies that separate noisy vendors from trusted partners.

The AI-Powered Influence Map: A New Blueprint for Healthcare Marketing Leaders

From Pitch Slaps to Genuine Partnerships: Your Roadmap to B2B Social Selling Improvement

From Pitch Slaps to Genuine Partnerships: Your Roadmap to B2B Social Selling Improvement

From Pitch Slaps to Genuine Partnerships: Your Roadmap to B2B Social Selling Improvement